GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Gross Margin %

AegirBio AB (AegirBio AB) Gross Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. AegirBio AB's Gross Profit for the three months ended in Mar. 2024 was $0.00 Mil. AegirBio AB's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, AegirBio AB's Gross Margin % for the quarter that ended in Mar. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for AegirBio AB's Gross Margin % or its related term are showing as below:

AEGBF' s Gross Margin % Range Over the Past 10 Years
Min: -1389.57   Med: -674.04   Max: 348.65
Current: 348.65


During the past 4 years, the highest Gross Margin % of AegirBio AB was 348.65%. The lowest was -1389.57%. And the median was -674.04%.

AEGBF's Gross Margin % is ranked worse than
99.88% of 801 companies
in the Medical Devices & Instruments industry
Industry Median: 52.83 vs AEGBF: 348.65

AegirBio AB had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for AegirBio AB was 0.00% per year.


AegirBio AB Gross Margin % Historical Data

The historical data trend for AegirBio AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Gross Margin % Chart

AegirBio AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Gross Margin %
- - 41.48 -1,392.68

AegirBio AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -233,200.00 -160.00 - - -

Competitive Comparison of AegirBio AB's Gross Margin %

For the Medical Devices subindustry, AegirBio AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AegirBio AB's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AegirBio AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where AegirBio AB's Gross Margin % falls into.



AegirBio AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

AegirBio AB's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=-2.3 / 0.164
=(Revenue - Cost of Goods Sold) / Revenue
=(0.164 - 2.448) / 0.164
=-1,392.68 %

AegirBio AB's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


AegirBio AB  (GREY:AEGBF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

AegirBio AB had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


AegirBio AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of AegirBio AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


AegirBio AB (AegirBio AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines